| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 13.223 | 28.922 | 36.696 | 45.335 | 48.749 | 59.716 | 69.151 | 89.911 | 100.766 |
| Total Income - EUR | - | 13.223 | 28.923 | 36.719 | 45.335 | 48.762 | 59.731 | 69.154 | 89.912 | 100.802 |
| Total Expenses - EUR | - | 9.526 | 20.983 | 22.315 | 25.879 | 34.540 | 34.917 | 39.206 | 49.447 | 67.711 |
| Gross Profit/Loss - EUR | - | 3.698 | 7.940 | 14.404 | 19.457 | 14.222 | 24.814 | 29.948 | 40.465 | 33.092 |
| Net Profit/Loss - EUR | - | 3.565 | 7.651 | 14.036 | 19.003 | 13.768 | 24.282 | 29.270 | 39.701 | 27.531 |
| Employees | - | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Novamedan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 9.499 | 8.106 | 6.749 | 5.433 | 8.416 | 6.288 | 6.209 | 27.939 | 19.402 |
| Current Assets | - | 5.090 | 11.038 | 18.651 | 27.782 | 29.364 | 42.087 | 43.895 | 37.036 | 32.339 |
| Inventories | - | 0 | 0 | 0 | 0 | 10 | 0 | 52 | 171 | 168 |
| Receivables | - | 2.154 | 2.110 | 3.116 | 4.133 | 4.655 | 5.344 | 4.970 | 13.378 | 310 |
| Cash | - | 2.936 | 8.928 | 15.535 | 23.649 | 24.700 | 36.743 | 38.872 | 23.487 | 31.861 |
| Shareholders Funds | - | 3.610 | 7.720 | 14.088 | 21.838 | 23.658 | 36.351 | 37.985 | 61.837 | 46.522 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 10.996 | 11.424 | 11.312 | 11.386 | 14.122 | 12.024 | 12.119 | 4.039 | 6.173 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Novamedan Srl